Drugs Made In America Acquisition II Corp. Announces the Separate Trading of its Ordinary Shares and Rights Commencing December 3, 2025
Fort Lauderdale, FL, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Drugs Made In America Acquisition II Corp. (the “ Company ”), a special purpose acquisition company formed as a Cayman Islands exempted company,...
Drugs Made In America Acquisition II Corp. Announces Closing of $500,000,000 Initial Public Offering
Fort Lauderdale, FL, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Drugs Made In America Acquisition II Corp. (Nasdaq: DMIIU) (the “ Company ”) today announced that it closed its initial public offering of...
Drugs Made In America Acquisition II Corp. Announces Pricing of $500,000,000 Initial Public Offering
Fort Lauderdale, FL, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Drugs Made In America Acquisition II Corp. (Nasdaq: DMIIU) (the “ Company ”) announced today the pricing yesterday of its initial public...